The background to the failure of the December 2001 Fifth Review Conference of the Biological and Toxin Weapons Convention (BTWC) to agree a politically binding final declaration is discussed. Negotiations in the Ad Hoc Group (AHG) of the BTWC, which was set up after the 1994 Special Conference, are described. Accusations of non-compliance with the BTWC are not new and it is concluded that the ultimate failure of the 2001 Review Conference was principally, but not entirely, due to rejection by the United States that the AHG should remain in being. Strengthening the BTWC remains as important as ever, but it remains to be seen if there is the political will to achieve this.
The UK committed itself to biological disarmament under the 1972 Biological Weapons Convention (BWC). Disarmament is not, however, something achieved at a specific point in time; it is a process of constant management of an obligation undertaken. Since 1975, when biological disarmament took effect, implementation of the Convention has altered to address the dynamic nature of threats, changes in political circumstances, and scientific and technological developments. In this article the approach of the UK to the BWC is studied to provide one lens on how a state implements and manages its biological disarmament obligation. Through an examination of the international, regional, and national policies adopted by the UK a process of continuous oversight is identified to deal with external threats from states, internal threats from terrorists, and the coordination of policy with many actors to maintain an effective biological disarmament architecture.T
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.